Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor-transporting protein 2 (RTP2) is a member of the zinc finger, 3CxxC-type protein family and acts as an accessory protein specifically facilitating the functional cell surface expression of mammalian olfactory receptors but not other G-protein-coupled receptors[1][4][11]. RTP2 enables olfactory receptor binding and is involved in protein insertion into the membrane, localizing primarily at the cell surface[1][10]. The gene is protein-coding, and although related diseases such as Bardet-Biedl syndrome 13 and familial glucocorticoid deficiency have been mentioned in association databases, direct causative or disease-driving roles are not well established[1]. RTP2 does not appear to be a common or validated drug target, nor is it directly implicated in major human diseases outside olfaction pathway variants[1][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor-transporting protein 2 (RTP2).